Recurrent abdominal pain as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in an Asian girl: a case report and review of the literature

J Microbiol Immunol Infect. 2014 Dec;47(6):550-4. doi: 10.1016/j.jmii.2012.07.003. Epub 2012 Aug 24.

Abstract

Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is characterized by periodic fever, cutaneous rash, conjunctivitis, lymphadenopathy, abdominal pain, myalgia, and arthralgia. It is a rare autosomal dominant disease and strongly associated with heterozygous mutations in the tumor necrosis factor (TNF) receptor super family 1A (TNFRSF1A) gene. It is believed to be more common in Western countries than in Asian countries. Here, we present the case of a 14-year-old girl with periodic fever and abdominal pain with elevation of inflammatory markers for 2 years. After extensive work-up of infectious etiology with negative results, the diagnosis of TRAPS was made although no gene mutations were identified in the TNFRSF1A gene, MVK gene, and NALP3/CIAS1 gene. She had partial clinical response to corticosteroids and immunomodulatory agents. However, the treatment response to TNF-α inhibitor etanercept was dramatic. She has remained symptom free under regular weekly to biweekly etanercept treatment for 2 years. We also reviewed the related literature and summarized the data of 10 Asian cases of TRAPS.

Keywords: Hereditary periodic fever; TNF-α inhibitor etanercept; Tumor necrosis factor receptor-associated periodic syndrome (TRAPS).

Publication types

  • Case Reports
  • Review

MeSH terms

  • Abdominal Pain / diagnosis*
  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Asian People
  • Carrier Proteins / genetics
  • Etanercept
  • Female
  • Fever / diagnosis
  • Hereditary Autoinflammatory Diseases / diagnosis*
  • Hereditary Autoinflammatory Diseases / pathology*
  • Humans
  • Immunoglobulin G / therapeutic use
  • Immunologic Factors / therapeutic use
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Phosphotransferases (Alcohol Group Acceptor) / genetics
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Receptors, Tumor Necrosis Factor, Type I / genetics
  • Recurrence
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Carrier Proteins
  • Immunoglobulin G
  • Immunologic Factors
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • TNFRSF1A protein, human
  • Tumor Necrosis Factor-alpha
  • Phosphotransferases (Alcohol Group Acceptor)
  • mevalonate kinase
  • Etanercept

Supplementary concepts

  • Periodic fever, familial, autosomal dominant